Preventing mother-to-child transmission
By 1994 more than a million infants worldwide have been born with HIV. In the USA, the antiretroviral drug AZT is approved to help prevent pregnant mothers pass HIV to their babies, following a study demonstrating a 67% reduction in transmissions. As a result, the World Health Organization also meets to discuss implications for developing countries, although roll-out is slow. Only 12% of those needing this treatment in the Middle East and North Africa have access to it in 2015.
Text and image
1994
http://www.bhiva.org/documents/Conferences/WorldAidsDay/2015/Presentations/DianaGibb.pdf
https://aidsinfo.nih.gov/news/137/azt-approved-for-preventing-maternal-fetal-hiv-transmission
Timeline date:
1994-08
iStock/MShep2